Postpartum

Metabolic

13 drugs in development·9 companies·2 clinical trials

Drug Pipeline by Phase

Approved(4)

Phase 3(2)

Drug	Company
lpcn 1154a	Lipocine Inc. (LPCN)
Oxytocin	Valneva SE (VALN)

Unknown(3)

N/A(2)

Drug	Company
Carbetocin	ENANTA PHARMACEUTICALS INC (ENTA)
Oxytocin	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 4(2)

Drug	Company
eptacog alfa	Novo Nordisk A/S (NVO)
ultomiris	ALEXION PHARMACEUTICALS, INC. (ALXN)

BioSniper tracks 13 drugs in development for Postpartum across 9 companies.

There are 2 clinical trials targeting Postpartum tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.